Details for Patent: 9,295,657

Which drugs does patent 9,295,657 protect, and when does it expire?

Patent 9,295,657 protects ADRENALIN and is included in two NDAs.

This patent has seven patent family members in seven countries.

Summary for Patent: 9,295,657

Title:	Epinephrine formulations
Abstract:	Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
Inventor(s):	Vinayagam Kannan, Patrick Irish, Michael Bergren
Assignee:	PH Health Ltd
Application Number:	US14/818,121
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,295,657
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 9,295,657

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ph Health	ADRENALIN	epinephrine	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	204200-001	Dec 7, 2012	AP	RX	Yes	Yes						EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS
Ph Health	ADRENALIN	epinephrine	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	204640-001	Dec 18, 2013	AP	RX	Yes	Yes						EMERGENCY TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS

International Family Members for US Patent 9,295,657

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016233682
Canada	2978464
China	107614017
European Patent Office	3268045